New drug combo shows promise in slowing rare gut cancers
NCT ID NCT01744249
First seen May 06, 2026 · Last updated May 21, 2026 · Updated 4 times
Summary
This study tested whether adding the oral drug axitinib to the standard treatment sandostatin LAR could slow cancer growth in people with advanced neuroendocrine tumors that started outside the pancreas. 256 adults with tumors that had recently grown were randomly assigned to get either the combination or sandostatin alone. The main goal was to see how long the cancer stayed under control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Azienda Ospedaliera Universitaria di Perugia
Perugia, 06129, Italy
-
Clatterbridge Cancer Centre
Bebington, Wirral, CH63 4JY, United Kingdom
-
Complejo Hospitalario Univ A Coruña
A Coruña, Spain
-
Hospital Alvaro Cunqueiro
Vigo, Pontevedra, 36312, Spain
-
Hospital Central de Asturias
Oviedo, Principality of Asturias, Spain
-
Hospital Clara Campal
Madrid, Spain
-
Hospital Clínico San Carlos
Madrid, Spain
-
Hospital General Universitario de Valencia
Valencia, 46014, Spain
-
Hospital Gregorio Marañón
Madrid, Spain
-
Hospital Marqués de Valdecilla
Santander, Spain
-
Hospital Univ La Paz
Madrid, Spain
-
Hospital Univ de Salamanca
Salamanca, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, Spain
-
Hospital Universitario 12 de Octubre
Madrid, Spain
-
Hospital Universitario Miguel Servet
Zaragoza, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, Spain
-
Hospital Universitario Virgen de la Victoria
Málaga, Malaga, 29010, Spain
-
Hospital Universitario Virgen del Rocío
Seville, Spain
-
Hospital Universitario de Burgos
Burgos, Spain
-
Hospital Virgen de las Nieves
Granada, Spain
-
Hospital de Donostia
Donostia / San Sebastian, Spain
-
Hospital universitario de Leon
León, Spain
-
Institut Català d'Oncologia L'Hospitalet
L'Hospitalet de Llobregat, Barcelona, Spain
-
MD Anderson Cancer Center
Madrid, 28033, Spain
-
Marburg Universitätsklinikum Giessen und Marburg GmbH
Marburg, 35043, Germany
-
Sapienza, Universitá di Roma, Ospedale sant'Andrea
Rome, 00189, Italy
Conditions
Explore the condition pages connected to this study.